WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
GILD
Pfizer Submits Covid-19 Pill for FDA Authorization
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
U.S. to Invest More Than $3 Billion in Covid-19 Antiviral Development
WASHINGTON—The Biden administration will invest more than $3 billion on developing and manufacturing antiviral pills to treat coronavirus, the Department...
Covid-19 Pill Shows Promise in Preliminary Testing
An experimental Covid-19 drug that promises to be a kind of Tamiflu for the pandemic had positive results in a...
